key: cord-0041898-0roxc0k4
authors: nan
title: Posters
date: 2018-06-14
journal: Pediatr Pulmonol
DOI: 10.1002/ppul.24034
sha: 8378c06d20103401c6b53cdbaa8dd053bd602745
doc_id: 41898
cord_uid: 0roxc0k4

nan

Increasing studies had demonstrated that early initiation of noninvasive ventilation, including the use of Bilevel Positive Airway Pressure (BiPAP), is safe and well-tolerated in the management of children having acute respiratory distress syndrome. Despite the proven efficacy in some pilot studies, the strategy of using BiPAP in asthma patients with severe dyspnea has not yet been well-adapted, and is thus termed "experimental approach" in guidelines. We conducted a retrospective study of children who were admitted to the pediatric intensive care unit (PICU) under the diagnosis of severe asthma exacerbation or status asthmaticus and were treated with or without BiPAP. The purpose of the study was to assess the treatment efficacy and tolerability of BiPAP.

We conducted a retrospective study on asthma patients who were admitted to PICU between January 2015 and February 2017. Patients with other significant comorbidities or with certain identified respiratory pathogens were excluded. For patients with multiple admissions, each admission was recorded separately. The medical records were reviewed for the following characteristics: age at presentation, clinical symptoms, heart rate (HR), respiratory rate (RR), oxygen demand, partial pressure of carbon dioxide in serum (pCO2), oxygen saturation (SpO2), clinical laboratory data and chest X-ray images. These admission data were grouped according to BiPAP use (Yes/No). Clinical parameters were documented at selected time intervals (before intervention, after intervention: 0∼2 hours, 2∼4 hours, 4∼8 hours, 10∼14 hours, 16∼20 hours and 24 hours). Time zero was defined as the initiation of BiPAP ventilation for the BiPAP-using group and any method of ventilation or oxygenation support at PICU for the non-BiPAP group. Mann-Whitney U test was used to analyze the serial data. Amongst the BiPAP(+) group, pCO2 and SpO2 were analyzed before and after the intervention using a paired T-test.

Data of 27 PICU admissions were obtained, four of whom were excluded for the reasons described above. Data of 23 admissions in 15 different patients were analyzed (19 with BiPAP and 4 without BiPAP).

The mean age at admission was 49.21 ± 33.82 months. Respiratory rate (RR) was significantly different before treatment between the 2 groups (p = 0.005) and 0∼2 hours after treatment (p = 0.047), with the BiPAP group having a higher respiratory rate. The RR improved significantly in the ensuing time intervals in the BiPAP group. For the heart rate (HR) analysis, there was no significant difference between groups for any time intervals. RR, HR and CO2 level all showed a decline in trend after treatment in both groups. In the BiPAP group, the decrease in pCO2 level did not show statistical significance, while SpO2 level improved significantly after the use of BiPAP. In our study, none received invasive mechanical ventilation support during PICU stay.

In this study, we found that there was a significant improvement in respiratory rate in patients with BiPAP support. BiPAP was also welltolerated compared with other means of non-invasive ventilation or oxygen support (nebulizer, mask). These improving trends were also reflected in RR, HR and CO2 similarly in both groups. In conclusion, BiPAP ventilation is safe and efficient in the relief of respiratory symptoms in children with severe asthma attack.

RubaTinA-asthma ® and PensieTinA-asthma ® studies regardless of whether they experienced episodes of asthma worsening or not, with the exception of the 2.5 μg dose group in the RubaTinA-asthma ® study ( Figures 1 and 2) .

Conclusion: Once-daily tiotropium as an add-on to ICS maintenance therapy ± other controllers generally improved lung function in patients aged 6-17 years with moderate or severe asthma irrespective of whether they experienced episodes of asthma worsening during the trials. These data support the demonstrated broad efficacy of tiotropium in this age group and indicate that improvements in lung function are largely consistent even if some patients experience episodes of disease worsening. Background: There has been little investigation on the safety and efficacy of new potential asthma medications in very young children (≤5 years). We evaluated the safety and efficacy of once-daily tiotropium Respimat ® (TioR) as add-on to inhaled corticosteroids (ICS) with or without further maintenance therapy in patients aged [1] [2] [3] [4] [5] years with persistent asthmatic symptoms.

Methods: In this Phase II/III, randomized, double-blind, placebo (PBO)controlled, parallel-group trial (NinoTinA-asthma ® , NCT01634113), patients aged 1-5 years with persistent asthmatic symptoms received tiotropium 2.5 μg (TioR 2.5) or 5 μg (TioR 5) or PBO as 2 puffs once daily for 12 weeks via the Respimat ® inhaler, as add-on to usual maintenance therapy of ICS with or without other controller medication. The primary objective was to determine the safety of TioR by comparing adverse events (AEs) with TioR versus PBO. The primary efficacy endpoint was change in the weekly mean combined daytime asthma symptom score from baseline at Week 12 (response).

The co-primary endpoint in 5-year-olds was peak forced expiratory volume in 1 second within 3 hours post-dose (peak FEV1(0-3h)) response. Exploratory analyses included 3 composite exacerbation endpoints derived from AEs, with treatment comparisons reported as hazard ratios (HRs). Treatment comparisons for efficacy endpoints were exploratory, and no formal hypothesis testing was performed.

Results: Of the 102 patients randomized, 101 were treated and completed the 12-week treatment period (TioR 2.5: n = 36; Figure) . At baseline, all patients used short-acting β2adrenoceptor agonists; after 12 weeks of treatment, less than half of the patients used any rescue medication. Use of rescue medication at

Week 12 (percentage of days per week) was comparable between groups (median of 0); however, there were differences in the upper quartile values between treatment groups (TioR 2.5: 42.9%; TioR 5:

28.6%; PBO: 50.0%), indicating that 25% of PBO-treated patients used rescue medication every second day, while 25% of the TioR 5-treated patients used rescue medication only every third day.

Conclusion: Our results suggest that tiotropium add-on therapy has a similar safety profile to PBO in preschool children with persistent asthmatic symptoms. Treatment with TioR resulted in some nonsignificant improvements in efficacy endpoints, including less frequent use of rescue medication, compared with PBO. Importantly, we observed a significant reduction in the number of children who

reported AEs related to asthma exacerbation or worsening in the TioR groups compared with PBO, pointing towards an increased disease control. Additional well-powered trials are needed to confirm our findings. When analyzed by month, reports of AEs related to asthma exacerbations and symptoms were greatest in the placebo group in the spring, autumn and winter ( Figure) , and lowest in summer.

With both doses of tiotropium, spring and autumn peaks were reduced. The study durations varied between 12 and 48 weeks, therefore, RR values were considered rather than hazard ratios (HR) alone.

Results: As an efficacy endpoint, the risk of exacerbation was generally reduced with tiotropium 5 μg add-on treatment compared with placebo (HR 0.60-0.82; Table 1 ), although these changes did not reach statistical significance. With tiotropium 2.5 μg, numerical reduction in risk of exacerbation was seen in 3 out of the 4 trials, ABSTRACT | S103 and this reached significance in VivaTinA-asthma ® (HR 0.52; 95% CI 0.33, 0.82). When analyzing patients reporting AEs related to asthma exacerbations or symptoms, there was also a reduction with tiotropium 5 μg versus placebo across the trials (RR 0.35-0.89; Conclusion: Overall, the data show that the 2 endpoints, exacerbations and AEs related to asthma exacerbations and symptoms, align and that treatment differences can be detected using AE reporting when exacerbation data as an efficacy endpoint are not, or cannot be, collected. Reductions in AEs related to asthma exacerbations or symptoms in safety reporting may be considered a useful alternative endpoint for clinicians and those conducting clinical trials to assess efficacy in terms of exacerbations in pediatric trials where sample size and trial duration may be limited. 6-17 years), as an example of how data from previous adult asthma studies can be extrapolated to pediatric asthma clinical trial programs.

Results: Several feasibility considerations were identified in the literature that can influence pediatric trial design. These ranged from low numbers of child participants in clinical research, poor longterm adherence in clinical trial settings, limited pediatric-specific resources at research centers and a lack of trial networks for pediatric research. Pediatric trials may also require the validation of specific endpoints for different age groups and associated stages of development.

While forced expiratory volume in 1 second (FEV1) is well accepted as an endpoint in clinical trials in adult patients, FEV1 response does not always correlate with asthma symptoms, and can often appear to be normal in children with asthma. 1 In the tiotropium in asthma clinical trial program, improvements in peak FEV1(0-3h) and trough FEV1

following tiotropium add-on therapy were in a comparable range in adult patients and pediatric patients ( Figure 1 ).

Alternative lung function measures suggested for pediatric patients include forced expiratory flow at 25-75% of the pulmonary volume (FEF25-75%), which reflects small airway function, and FEV1/forced vital capacity (FVC) ratio, which has been shown to be associated with asthma severity in children. In pediatric patients, tiotropium add-on therapy consistently improved trough FEF25-75% responses versus placebo. There was a strong association between improvements in trough FEF25-75% and trough FEV1

(Pearson correlation coefficient 0.735-0.799), and FEF25-75% improvements were largely more pronounced than trough FEV1 improvements. Moreover, tiotropium add-on therapy consistently improved trough FEV1/FVC ratio versus placebo in pediatric patients, although a high variability was noted in adolescent patients with severe asthma.

In addition to lung function-based endpoints, it is important to study patient-relevant outcomes such as exacerbations and symptoms. Assessing these endpoints in a confirmatory design can require a large sample size and a long study duration. Such trials would require giving some children placebo for long periods, which may be unethical, especially in the pediatric setting. Because asthma is a disease that follows a similar course in adults and children, and outcomes of treatments are comparable, a partial extrapolation concept was applied in the tiotropium in asthma clinical trial program. Thus, in adult patients, lung function, symptom and exacerbation endpoints were evaluated in a confirmatory manner, while in pediatric patients, only lung function endpoints were evaluated in a confirmatory manner, and symptom and exacerbation endpoints were assessed in an exploratory manner.

In adults (aged 18-75 years), tiotropium add-on therapy significantly improved pulmonary function and asthma control, and reduced exacerbation risk versus placebo. In pediatric patients (aged 6-17 years), tiotropium add-on therapy largely improved pulmonary function versus placebo, and there were trends for improved asthma control and reduced exacerbation risk versus placebo in a comparable range, as in adult patients.

The results from the tiotropium in asthma clinical program emphasize that successful clinical trials in pediatric patients with asthma can be performed. To assess lung function, FEV1 and FEF25-75% were shown to be reliable endpoints. In addition, there was a strong, positive correlation between trough FEF25-75% and FEV1, and trough FEF25-75% responses were generally more pronounced than FEV1 responses. The tiotropium asthma clinical program also demonstrated how a partial extrapolation concept may be applied for exacerbation and symptom endpoints, thereby keeping sample size and study duration reasonable and in line with ethical considerations. Results: Exposure to passive smoking was present in 55% of the children.

Household agglomeration, lower family income, lower level of maternal and paternal schooling were significantly observed in the exposed group.

The exposed population showed a higher frequency of asthma classified as moderate, greater use of inhaled corticosteroids and greater frequency of diurnal symptoms (present at least once a week in 60% of patients).

The prevalence of asthmatic children exposed to passive smoking was high. Low socioeconomic condition was confirmed in the exposed group. Moderate severity, greater use of inhaled corticosteroids and greater frequency of diurnal symptoms were observed in the exposed group. Effective measures to combat passive smoking should be taken immediately as an essential strategy for the control of childhood asthma. Introduction: There is disagreement among Spanish pediatrician experts relative to asthma diagnosis in infants and preschoolers. We present the results of a systematic review of asthma guidelines to answer some key questions regarding the diagnosis of asthma in infants and preschoolers, as a preliminary step to reaching a consensus among Spanish pediatricians on this subject.

Is there a specific definition for asthma in children under 6 years old?

Is it possible to diagnose asthma at any age, including the first year of life?

Is it necessary to perform pulmonary function tests in order to make the diagnosis of asthma in children under 6 years of age?

Are there defined and objective criteria for the diagnosis of asthma in children under 6 years old?

Is it possible to diagnose asthma in preschoolers even though the disease may remit at 6 years of age or later? AND ("Asthma"Mesh OR asthma*ti), without restriction of languages.

A manual search was subsequently performed.

Inclusion and exclusion criteria: We included CPGs that aimed to provide diagnostic and therapeutic recommendations on the care for children and/or adolescents and adults. The documents were considered as a guideline if they met the following criteria: provided practical clinical recommendations for children, adolescents or adults, and collected all related documents and supporting materials. We excluded documents without information regarding the concept or diagnosis of asthma in childhood, including the first 6 years of life.

Analysis: The guidelines included in the review were subjected to several exploratory analyses conducted by LM, with the participation of all the researchers. Given the descriptive nature of the sections related to the concept and diagnosis of asthma, questionnaires were designed to find out how the guidelines considered the diagnosis of asthma in young children, especially in terms of the age at which it could be established, the diagnosis and the premises (clinical criteria or complementary tests) to make this diagnosis. The authors responded to these questionnaires and they contributed with comments via email to clarify the discrepancies. Discrepancies were resolved by agreement among reviewers.

We obtained 2338 references with the initial search in Trip Database and PubMed ( Figure 1 ). Through manual search, we added 7 more guides. Finally, 22 documents were analyzed and grouped into 20 guides, given that 2 of the guides were considered to be integrated by 2 different documents whose contents were judged as complementary. Nine guidelines referred to patients of all ages, 8 were pediatric and 3 were dedicated exclusively for preschoolers. Regarding questions, the results were:

In most guidelines, the concept and definition of asthma are closely linked to their diagnosis. In the general guidelines, distinction is not made between the definitions of adult or pediatric asthma.

Most asthma guidelines recognize, generally implicitly, that there is not an age limit to establish the diagnosis of asthma, but highlight the difficulty to establish the diagnosis under 5-6 years.

Spirometry is not considered essential to establish the diagnosis in preschoolers, although the difficulty in carrying it out is an inconvenience that makes it difficult to confirm the diagnosis.

In most of the guidelines, asthma diagnosis in preschool children is based on the subjective interpretation that the pediatrician makes of the clinical findings, treatment response and exclusion of other alternative diagnoses. They also rely on the performance of some complementary tests that rule out or increase the probability of diagnosis.

The ERS guideline on preschool wheezing is the only one to indicate that the disappearance of symptoms in later years is what distinguishes those who really suffer from asthma from those who do not. Some guidelines accept that asthma may remit over time (for example, ICON and Japan's child) and, therefore, it would not be an impediment to establish the diagnosis.

Conclusion: There is an apparent agreement among most national and international guidelines to consider that the diagnosis of asthma in preschool child is syndromic and that it can be established at any age, even though respiratory function tests cannot be performed.

Reflection: We believe that there is, therefore, a good basis for the performance of a consensus that formalizes the findings of this review.

glutamine and branched-chain amino acids (Gardiner & Barbul, 2001) .

These amino acids have been used in sepsis, burn, surgical and trauma patients who presented with a significant decrease in their plasma arginine level, which correlated with their state of immunosuppression incurred by the initial insult.

This study evaluated Arginine supplementation as an adjuvant therapeutic option among patients with healthcare-associated pneumonia as a potential agent to specifically alter the inflammatory response and immune function of an individual during the disease process that is measured indirectly by soluble human leukocyte antigen type DR (sHLA-DR) level.

Objective: To determine the effect of adjunctive arginine therapy on the immune status of pediatric patients diagnosed with healthcareassociated pneumonia.

Study Design: Randomized, Double-Blinded, Placebo-Controlled Trial Methods: All patients aged 1 month old to 18 years old admitted at the Pediatric ER, Wards 6, 9, 11, Trauma and Burn Unit, diagnosed with a first bout of healthcare-associated pneumonia regardless of the current hospital stay, empirically treated with IV antibiotic and on enteral nutrition either per orem or through feeding tubes, were included in the study. Patients who were enrolled in the study were randomized into two (2) groups by means of a computer-generated randomization table.

One group received the dietary supplement and the other the placebo.

The dietary supplement group received L-arginine 200 mg/kg/day three times a day per orem for 7 days as an adjunct to the appropriate intravenous antibiotics not exceeding 3 grams/day. Blood samples were collected from all recruited subjects for baseline levels of plasma arginine and serum sHLA-DR and repeat blood extraction after 7 days of supplementation and treatment for healthcare-associated pneumonia.

Data were encoded in Microsoft Excel and analyzed using SPSS. All variables were numerical variables and expressed as mean and standard deviation. All variables underwent T-test for numerical variables. Pearson correlation was also used to test the relationship of the plasma level of L-arginine with sHLA-DR level between the dietary supplement and placebo groups.

Results: There were a total of 40 patients recruited in the study. Seven (7) subjects were withdrawn from the study; five (5) of whom were due to protocol non-compliance and two (2) had deceased due to acute respiratory failure as complication of the underlying disease, thus only 33 subjects were included. There were 16 and 17 subjects recruited to the respective supplement and placebo groups. There was no significant difference between the two groups in terms of age, weight, gender and use of oxygen support.

The Arginine levels on Day 1 of both supplement and placebo groups were the same and showed no significant difference (p value = 0.71).

The Arginine levels on Day 8 of the supplement group however had a higher level compared to the placebo group but was not statistically significant (p value = 0.27). Regarding the sHLA-DR levels of both groups, the supplement group had a lower level on Day 1 as well as after supplementation (Day 8) compared to levels of the placebo group. Both sHLA-DR levels of the two groups were not statistically significant. However, both sHLA-DR levels of both groups were below the set threshold level, hence both groups had low sHLA-DR levels.

Further analysis of the data comparing arginine and sHLA-DR levels on day 1 to levels after 7-day supplementation (Day 8) showed that, in the supplement group, arginine levels at baseline and after 7 days of supplementation increased which was statistically significant (P value = 0.04). In the placebo group, the Arginine levels at baseline and after 7 days of supplementation also increased, however they were not significantly different (P value = 0.31).

Data on arginine and sHLA-DR levels both at baseline (Day 1) and after 7 days of supplementation (Day 8) were compared although showed no correlation between the level of arginine and sHLA-DR in both groups with Pearson's r values of less than 0.8. Results: This study showed that there was a prevalence rate of 0.35% for extrapulmonary TB among all pediatric admission for the years 2014-2016. The majority of the cases were children aged 1-5 years old, 64% with a mean age 10 years old. There appeared to be no sex predilection with regards to extrapulmonary TB. A majority of the cases had no known TB disease or TB exposure. Common cases of EPTB included TB meningitis (84%) presenting with changes in behavior or decrease in sensorium. Gastrointestinal TB (8%) presented with abdominal distention and one case of TB Uveitis who presented with whitish lesion in the cornea of the eye. Among these patients, 33% were discharged as improved including and 42% died all of whom were TB meningitis patients.

Conclusion: With these data, we can say that there is a need to strengthen the National TB program in terms of active case finding so that we can further decrease the transmission of TB in the country and initiate early treatment. There is also a need to educate health care workers to identify possible cases of EPTB to prevent possible fatal outcomes. Since TB meningitis has a poor outcome, health care professionals should be vigilant and be more aggressive in treating these cases. Results: There were 74 children in the study group and 153 children in the control group. Overall, 52% of children in the study group and 54% of children in the control group had passive smoking exposure. Urine cotinine / creatinine levels of children exposed to passive smoking were higher than unexposed children. There was a significant difference between the study and control groups in terms of age, monthly income, number of people living at home, age of mother and father, and time spent outside the home (p < 0.05). The cotinine / ABSTRACT | S113 creatinine level of the study group was higher than the control group.

There was a significant difference between age and urine cotinine / creatinine levels in mild and severe cases in the study group (p < 0.05); 64.1% of the children with smoking exposure had severe pneumonia while 35.9% had mild pneumonia. ROC analysis revealed a urine cotinine / creatinine threshold of 2.47 ng / mg for passive smoking exposure.

Discussion: Objectively, it was shown that passive smoking exposure is associated with the development of severe pneumonia in children. The present findings are considered as promising given that the threshold value of passive smoking exposure after smoking cessation in our country was considerably lower than in previous studies.

Mycoplasma pneumoniae Pneumonia in Children. Methods: A retrospective, observational study of NP cases caused by RMPP, who were hospitalized in our hospital from January 2008 to December 2015 was conducted, and clinical manifestations, laboratory data, imaging performance, hospital course and outcomes were analyzed.

Results: A total of 25 NP cases caused by RMPP were identified, with a median age of 5.1 (4.0 ∼ 7.9) years. The mean length of total fever days and hospital stay days of these patients were 21.0 ± 8.9 days and 19.9 ± 9.9 days, respectively. The abnormal laboratory findings of elevated C-reactive protein (CRP), lactate dehydrogenase (LDH), interleukin (IL)-6, IL-10 and interferon gamma (IFN-γ) were observed in many of our patients. Meanwhile, pleural fluid characteristics associated with NP in the present study, particularly the high value of pleural fluid cell count, LDH and protein, was also observed. Most of the patients (80.0%) in our study were associated with pleural effusion, and had a high incidence of lobar atelectasis and pulmonary consolidation. Interestingly, the mean delay time for detecting necrotic lesions from onset of symptoms was 21.0 ± 6.9 days. Eighty percent Results: The median age was higher in patients with early-onset complications (ECx) than in those without ECx, while it was not different between patients with and without late-onset complications (LCx). The median levels of lactate dehydrogenase (LDH), C-reactive protein, ferritin, C-X-C motif ligand 9, C-X-C motif ligand 10, interleukin (IL)-2Rα, IL-10, IL-18, interferon-γ and the median percentage of neutrophils in patients with ECx were higher than in those without ECx. In logistic regression analysis, ferritin >37.01 pg/mL (OR 11.75, 95% CI 1.07-229.29) and IL-10 >809.13 pg/mL (OR 6.57, 95% CI 1. Background: Indonesia has one of the highest tuberculosis incidence globally. Miliary tuberculosis is a severe form of tuberculosis that is due to lymphohematogenous spread. Miliary tuberculosis occurs more often in younger or immunocompromised children. However, miliary tuberculosis in older age groups is rarely reported. History of low grade fever, chronic cough, loss of appetite, decreased body weight, nodules in the neck, armpit, upper chest, no pain, since 1 year. Then, in 1 month, the nodules became reddish and ruptured, discharging pus, after which other nodules started to appear. We found signs of dyspnea with rales, multiple hypertrophic crusted ulcers with skin tract at the colli, axilla and infraclavicular regions, abdominal enlargement due to ascites and edema of the leg, and clinical marasmic kwashiorkor. Tuberculin skin and HIV rapid tests were negative, a rapid molecular test detected very low Mycobacterium tuberculosis (Mtb), and hypoalbuminemia. Skin biopsy showed specific chronic ABSTRACT | S115 inflammatory granulomatous. Anti-tuberculosis therapy (ATT), albumin, antibiotic, and nutritional therapy was administered. Significant improvement was observed after 1 week of treatment. Results: From the overall 50 pediatric TB patients, 20 were males and 30 were females. Pulmonary TB was more common (76%) than extrapulmonary TB (24%). BCG scar was present in 50% of cases.

History of TB contact was present in 2%. The most common symptoms were fever (72%), cough (70%) and malnutrition (40%). Tuberculin skin testing was positive in 68%. GeneXpert was positive in 46%. in under 5 years old and 5-14 years old, respectively (p = 0.03).

Conclusion: Incidence of extrapulmonary TB was found higher in adolescence, and history of contact was higher in pulmonary TB. Follow-up and identification of late sequelae were also studied.

Results: A total of 77 children fulfilled the study criteria, with a median age of 19 months, 55% being girls. The most frequently identified virus was RSV (n = 42) followed by adenovirus (n = 23), rhinovirus (n = 22), parainfluenza (n = 12), influenza A (n = 10), metapneumovirus and coronavirus (both with n = 9). Mycoplasma was identified in two children. Most patients (60%) had more than one virus identified, and three children had no identified pathogen. Median time of hospitalization was five days, ranging from one to 17 days. Most children were treated with supportive measures, but three children needed mechanical ventilation. Fifty-three children were followed-up at our hospital. Of those, 20 are still followed at the Pulmonology Outpatient Clinic: 2 with post-infectious bronchiolitis obliterans (both diagnosed clinically and with CT scan) and the remaining for recurrent wheezing and/or cough not present before the pneumonia.

The remaining children maintain follow-up at a primary care or local hospital but none of them has been identified with respiratory sequelae. Objective: This study sought to identify the risk factors for severe pneumonia among children under-5 years of age in Costa Rica.

Methods: A case control study was conducted including children under-5 years old who were admitted to the Children's Hospital in Costa Rica between January 2010 and January 2015. The sample size calculation that was performed assuming a 95% level of confidence and 5% margin of error estimated a total of 160 patients overall. A convenience sampling technique was used to select 80 children with severe pneumonia (cases) and 80 children with non-severe pneumonia (controls) matched for age.

Cases and controls were defined by clinical criteria following WHO recommendations. All medical records were reviewed to collect data on socio-demographics, nutritional status and risk factors.

Results: The mean age of the patients was 18.2 months (range, 2-58 months), without significant difference between cases and controls. A slight predominance of male sex was observed within the severe pneumonia group, 63.7% versus 50% in the control group (p = 0.07).

Ethnicity was also found to be highly associated with severe pneumonia since 14 (17.5%) patients in the severe pneumonia group were indigenous compared to none in the control group (P < 0.0001).

On bivariate analysis, malnutrition, (OR:2.6,95% CI: 1.3-5.4, p = 0.005), prematurity (OR:3.2, 95% CI: 1.3-8.0, p = 0.004), low-birth weight (OR:2.8, 95% CI: 1.1-7.8, p = 0.02), lack of breastfeeding for at ABSTRACT | S119 least 6 months (OR:2.1, 95% CI: 1.1-4.3), p = 0.02) and co-morbidities (OR: 2.2, 95%CI:1.1-4.4, p = 0.01) were significantly associated with severe pneumonia. A total of 28 (35.0%) cases were exposed to passive smoking versus 18 (23.1%) controls. An increasing trend of severe pneumonia was observed among children exposed to tobacco smoking by the parents, although not statistically significant (OR:1.7,95% CI: 0.8-3.8, p = 0.09). No associations were found between severe pneumonia and other environmental factors such as exposure to cooking smoke and prenatal smoking, or living in crowded homes.

Within co-morbidities, asthma (OR:2.1, 95% CI: 1.1-4.6, p = 0.02) was by itself the only condition associated with severe pneumonia. Linear logistic regression showed that being indigenous was the only independent risk factor for development of severe pneumonia (p = 0.003).

Conclusions: In our study, we found that malnutrition and lack of breastfeeding are modifiable risk factors related to severe pneumonia in young children. Other factors highly associated with severe pneumonia were ethnicity, prematurity, low-birth weight and comorbidities. Although passive smoking was not a significant risk factor, the general prevalence found in both groups was higher than the mean prevalence of smoking in Costa Rica. On the other hand, adequate vaccination and at least 6 months of breastfeeding were associated with mild disease and better outcomes. Mortality rate in our cohort was low compared to studies in LMICs. Viral infections were present in a high proportion of patients with CAP in our study.

Since severe pneumonia is preventable, clinicians and public health authorities can play significant roles to reduce its occurrence through health promotion, educational activities and effective child health programs, particularly in high risk groups. Purpose of the case: This case emphasizes the importance of considering Nocardia in differential diagnosis of pulmonary abscess, especially in the absence of response to empiric therapy.

Case report: We report a case of a previously healthy 17-year-old adolescent who was admitted in the ER with a history of fever, odynophagia, vomiting, cough and thoracic pain. The patient was on day 2 of amoxicillin/clavulanate for a pultaceous tonsillitis. On admission, exudate was observed on the tonsils but there were no signs of peritonsillar abscess. The pulmonary auscultation was normal.

On blood tests, the total white cell count was 12,020/uL with 86.5% neutrophils and 2.8% lymphocytes (340/uL). Serum C-reactive protein (CRP) was 130.2 mg/L. Heterophile antibody test was negative and chest X-ray revealed an interstitial infiltrate in the right upper lobe. The patient was discharged with increased dose of amoxicillin/clavulanate.

The adolescent returned to the ER eight days later with recrudescence of fever, dyspnea and thoracic pain. On blood tests, the total white cell count was 19,500/uL with 76.9% neutrophils and 12.1% lymphocytes Background: Tuberculosis (TB) in childhood is clinically challenging, but it is a preventable and treatable disease. The most common form of pediatric TB is pulmonary disease; however, other extrapulmonary forms of TB such as miliary, lymphatic, meningitis and others are also common, particularly in children. According to WHO, Costa Rica is considered a low TB incidence country (9.5 cases per 100 000). Nevertheless, this disease should be considered to be a public health threat in any country. In Costa Results: A total of 54 cases of diagnosed extrapulmonary disease were identified, of which 20 (37%) were miliary TB, followed by 14 (25.9%) cases with meningeal tuberculosis, 13 (24.1%) with tuberculous lymphadenitis, 3 (5.6%) pleural TB, 2 (3.7%) osteoarticular TB, and gastrointestinal and skin involvement in equal proportions in 1 (1.9%) patient. The mean age of diagnosis was 5.2 years (range, 0.4-12.8 years). A slight predominance of male sex prevalence was observed, with 57.4% in comparison to 42.6% female distribution. As expected, the majority of patients (47, 87.0%) were from Costa Rica. Immigration is also common in the region, from our cohort: 5 (9.2%) were from Panama and 2 (3.7%) cases from Nicaragua. There were 15 (27.7%) cases of extrapulmonary TB among the indigenous population, 3 (20%) came from Panama. No HIV positive cases were found, and malnutrition was present in 22.2% of cases.

Information collected regarding the adult index case was available for 50 patients of which only 29 (58%) had a positive index case.

The most frequent symptom was fever in: 75% of miliary cases, 66.7% of pleural tuberculosis, 64.3% meningeal presentation, and 46.2% in ganglionar disease. As for miliary tuberculosis, chronic cough was present in 60% of cases and weight loss in 45% of cases, with respiratory distress and enlarged liver in 35% of cases. Lymph Conclusion: The epidemiological characterization of pediatric patients with extrapulmonary TB helps achieve a better diagnostic approach to this population. It is clear that bacterial confirmation is difficult in children with disseminated disease; therefore, contact history, clinical features, radiology and TST may be sufficient to establish a diagnosis and initiate treatment. In our study, although microbiological isolation was low, it was slightly higher to other similar reports. The role of molecular biology for TB diagnosis is an important development, however, in our study, this technique was not available during the whole study period. We found that prompt diagnosis is dependent on a high index of suspicion as clinical signs may be non-specific and microbiological confirmation is difficult.

Furthermore, the tuberculin skin test and chest radiograph may initially be negative in as many as 40% of pediatric patients.

Treatment was well tolerated in most patients. The patient underwent right bilobectomy for assumption of malignancy.

Inflammatory pseudotumor was an initial histological diagnosis.

However, due to high clinical suspicion of primary lung malignancy, combined partial resection of the left lung was performed. The second revision of the histological material suggested a fungal nature of the disease (sporotrichosis). Despite the absence of clinical signs of immunodeficiency, mycological examination was conducted. BAL microscopy, PCR, bacteriological culture, galactomannan test, revision of histological material with a specific Grocott's stain were performed.

On the follow-up CT examination, a nodule in the S2 left upper lobe was found (Fig 2) . Specific processes and postoperative changes were found in differential diagnosis. The third expert pathology review of the histological samples was requested. Histological examination revealed significant lymphoplasmacytic infiltrate with lymphoid follicle formation, peribronchial fibrosis, vascular obliteration (Fig. 3a) . 

IgG4-related disease is a rare disease, especially cases with lung involvement . It can mimic malignancy, infection or inflammatory disorders. Isolated pulmonary disease is most frequently seen in middle aged and older men but young people can also present with this disease. Biopsy is required for the diagnosis of IgG4-related disease. 

A total of 40 patients were enrolled into our study. The median onset age of mediastinal tumors was around 13 years-old. Male to female ratio was 3 to 1. The overall mortality rate was up to 40%. Only two cases were benign in origin. The most common tumor type was lymphoma (40%), followed by germ cell tumors (12.5%), neuroblastoma (12.5%), and thymoma (7.5%). Neuroblastoma was more prevalent in girls younger than 5 years-old. The initial presentations of these patients included respiratory distress (60%), productive cough (47.5%), pleural effusion (42.5%), superior vena cava (SVC) syndrome (35%), neck mass (35%), airway compression (32.5%), fever (30%), chest pain (25%) and pericardial effusion (25%). Lymphoma, compared to other types of tumors, was more likely to be accompanied with neck mass (52.6% vs.19.0%, P = 0.026) and SVC syndrome (52.6% vs.

19.0%, P = 0.026), yet had better one year-survival rate (68.4% vs.

52.4%, P = 0.021). ABSTRACT | S123

Pediatric mediastinal tumors often involve the respiratory system.

Overall, lymphoma should be highly suspected when children present with neck mass and SVC syndrome, and are more common in male teenagers. Lymphoma also has better prognosis compared to other types of malignancy. Neuroblastoma, from posterior mediastinal origin, should be considered in priority among children younger than 5 years old. treat massive pleural effusion other than to define its source. Revision of the distal tip of the VP catheter may be sufficient when malfunction is suspected, especially when the effusion is not massive and the clinical picture does not suggest catheter infection. Its removal from the pleural space and repositioning back into the abdomen or in the right atrium is considered when dislocation is showed or CSF hydrothorax is recurrent [3] . Positive pressure ventilation is also reported as a possible therapeutic approach because of its effect on conversion of negative intrathoracic pressure to positive, preventing fluid shifts [4] . 

Clinical symptoms of TM do not completely resolve with child's age.

And until early school age, the most common persistent symptom is prominent postinfectious cough, which is characterized as barking or unusual in sound. In over one third of children with TM, exercise intolerance due to cough is also present. Respiratory tract infections diminish in frequency and severity with child age. Primary care physician should be aware of the evolution of TM symptoms to avoid unnecessary treatment. According to WHO, asthma is the most common chronic disease among children. Therefore it is not surprising that if a child presents with a chronic respiratory symptoms to a physician, the latter's first thought and probably therapeutic management would be about asthma.

We present a case of an 11-year-old girl referred to our clinic after being treated for asthma without success for more than 6 years and labeled as "difficult to treat, uncontrolled asthma". From the past medical history, the following findings were notable: breast-milk aspiration at the age of 1 day (confirmed hypoventilation in the left lung), esophageal stricture surgically corrected at the age of 1 month, recurrent wheezing since infancy, food allergy and pet allergy. From the family history: elder brother with confirmed CF (the girl was born after pre-natal screening for CF and she was tested as carrier) and elder sister with epilepsy. At admission the notable findings were difference in both circumferences of the thorax (the left was larger than the right), diminished lung sounds on the right with crackles and rales. From the tests, we found negative bronchodilatatory response with predominant restriction on spirometry, right lung smaller in size compared to the left on X-ray of the lungs. CAT confirmed our suspected diagnosis − lung hypoplasia. The therapy was modified according the confirmed diagnosis and the asthma control medications were discontinued. For the following 6 months, no significant medical problems were noted, as well as no "asthma exacerbations".

We present the case as an illustration that not all "difficult to treat asthma" patients are really stricken with asthma. The correct diagnosis requires a comprehensive investigation-including an in-depth history and physical examination, pulmonary function studies, X-rays, laboratory studies, endoscopy, and specialized studies (e.g. allergy Case Report: A 9-year-old boy presented with hemoptysis for 3 days and prolonged cough for 3 months. There was no fever or constitutional symptoms such as loss of weight, loss of appetite or night sweats. There was no pulmonary tuberculosis contact.

Antenatal history was significant for maternal pre-eclampsia with severe fetal intrauterine growth retardation. He was born at 35 weeks of gestation, with birth weight of 1530 grams. There were no respiratory symptoms in the neonatal period.

This child also had a history of asthma and allergic rhinitis. His first wheezing episode was when he was a few months old, with subsequent wheezing episodes a few times a year. His wheezing episodes were preceded by fever and upper respiratory tract infection symptoms, and responsive to bronchodilators. He was asymptomatic in between the wheezing episodes. He was started on inhaled corticosteroids (ICS) from the age of 2 to 3 years old, after which he did not return for further review. He presented again after an admission for asthma exacerbation at 7 years old. Spirometry demonstrated mild bronchodilator response and he was restarted on ICS. Although nonadherent with his ICS, his wheezing episodes were infrequent. His grandfather has asthma and allergic rhinitis, and smokes at home.

Physical examination, including the respiratory system, was unremarkable. There was no digital clubbing, lymphadenopathy or abdominal organomegaly. Chest X-ray revealed a right upper lobe cavitary lesion, raising the concern of pulmonary tuberculosis. Blood and sputum investigations for bacterial, fungal and mycobacterial infections were negative. Mantoux test and human immunodeficiency virus screen were negative. Hypochromic, microcytic anemia (hemoglobin 7.3 g/DL) was noted, secondary to iron deficiency (low serum iron and ferritin, elevated serum transferrin). Occult blood was positive in his stools. Blood coagulation profile was normal. Although symptoms of CBPFM usually present during infancy, the diagnosis was delayed in this child. CBPFM has been diagnosed in late childhood and adulthood, possibly related to non-specific symptoms or vague presentation. It is not clear if the asthma symptoms and wheeze in this child were related to the CBPFM, although he has features of atopy.

Further follow-up of symptoms and pulmonary function will help clarify. Aim: Pediatric interstitial lung disease (chILD) has been associated with high morbidity and mortality, and previous studies suggest that outcomes may be poor especially for infants and young children due to failure to thrive and weight loss in this group. Anorexia, difficulty in feeding, and increased energy expenditure from increased work of breathing may lead to failure to thrive and weight loss. Therefore it is important to know details of the effects of nutrition on mortality and morbidity of chILD. The aim of this study was to assess the relationship between nutritional status and pulmonary exacerbations, lung function tests and the severity of the disease in chILD. Results: During the study period, 37 patients were included into the registry. The mean diagnostic age was 6.6 ± 5.5 years (0.1-18 years) and Male/Female ratio was 21/16. At first evaluation, the mean FEV1%, FVC%, FEF25-75% and DLCO% were 79 ± 18, 78 ± 18, 90 ± 33 and 62 ± 24, respectively. Patients had pulmonary exacerbations ranging from 1 to 30 in total before the diagnosis of ILD. BMI had moderate negative significant correlation with Fan 5 severity score. BMI had moderate positive significant correlation with oxygen saturation. BMI had no significant correlation with number of pulmonary exacerbations and lung function tests in our cohort.

However BMI had moderate positive correlation with DLCO. Partial IgA deficiency has not been reported with KS previously.

We report a case with classic KS who also had partial IgA deficiency born in a family with six individuals with KS. Conclusion: In the case described, it is important to draw attention to the differential diagnosis of recurrent pneumonia cases of the same location. In the present case, due to the family history of tuberculosis, a high prevalence of the disease in Brazil, tuberculosis was investigated.

However, the investigation was negative. Bronchoscopy examination with biopsy was decisive for the diagnosis. In young patients, those with well circumscribed lung mass and non-specific respiratory symptoms, the diagnosis of inflammatory pseudotumor (IPT) should be considered. 

Eventration of diaphragm is a congenital disorder in which all or part of the diaphragmatic muscle is replaced by fibroelastic tissue. The weakened diaphragm may be displaced into the thorax and compromise the patient's breathing. Complete eventration almost invariably occurs on the left side and is rarely on the right side. We present a premature female infant whose right-side diaphragm eventration was first noted at one month of age, although the previous CXR films showed normal bilateral diaphragmatic levels.

The 3-month-old female infant, with a history of symmetric SGA (bityh body weight 2400 g at 39 + 4 weeks of gestation) and multiple congenital anomalies, was referred to our hospital due to a deterioration of respiratory distress. She suffered from remarkable chest retractions at admission with a loud and high-pitch stridor sound. CXR showed increase infiltrations in bilateral lung field and a round-shape patch in the RLL area.

Clinically, we provided support with nasal CPAP and chest physiotherapy, but the respiratory distress, stridor sound, and RLL patch persisted.

Therefore, we arranged a bronchoscope study and noted a severe degree of laryngomalacia. We also examined the diaphragm movements with a fluoroscope, and found a remarkable eventration deformity of the rightside diaphragm at its posterior aspect by 3 rib spaces. (No paradoxical movement of the right diaphragm, and no herniation of abdominal contents into the thoracic cavity). Laser therapy to reconstruct the severe laryngomalacia and right diaphragm plication via abdominal approach to pull down the elevated diaphragm were undertaken. She improved in breathing and feeding and began to gain weight afterwards, and was discharged smoothly.

Although diaphragm eventration is a congenital defect, the case we present display a late development of right diaphragm eventration at one month of age. We suspect this to be a combination effect of both diaphragm muscle weakness of the right side and a high negative pleural pressure associated with the severe laryngomalacia. To date, we have not found any literature report mentioning this type of "late Participants did not report many symptoms, but MP adolescents reported more (dry) cough (MP 22% vs. FT 3%, p = 0.016) and hayfever (MP 32% vs. FT 9%, p = 0.015) than FT. MP did not report more wheeze, dyspnea, asthma or eczema during the last twelve months.

Most lung function measurements including LCI were within the normal range for both groups, except PEF (MP 86% pred vs. FT 93% pred, p = 0.05) and MEF75, (MP 86% vs. FT 96%, p = 0.06) which were at the lower limit of normal in MP. We observed no differences between the groups in maximal workload, maximal VO2, breathing frequency, ventilatory reserve, and BORG score. (See also table 1).

Conclusion: Moderate preterm birth has little impact on respiratory health in adolescence. Adolescents born MP report few symptoms (but more than FTs), have only mild lung function abnormalities compared to FTs and do not differ in the maximal exercise test and in physical activity level. Improvements in survival are continuously accruing in people with cystic fibrosis (CF) and appear to be evident in sequential birth cohorts [1] . As We observed that Galectin 9 protein concentration was significantly higher in CF patients during exacerbation (9.74 ng/ul) and stable period (9.57 ng/ul) than in healthy control subjects (6.55 ng/ul) (both p values below 0.001). Concentration of Gal-9 was significantly higher in sputum than in blood (p < 0.0001). No significant correlation was observed between Gal-9 concentration and disease severity (SK score).

Gal-9 level correlated with disease progression (exacerbation within 3 months from inclusion in the study, changes in radiological picture, lung function); we observed a significant correlation with FVC decline (p = 0.025), but not with the other analyzed progression markers.

Galectin 9 seems to be related to airway inflammation in CF and may be a marker of lung function decline, mainly vital capacity reduction, and a marker of future exacerbations. has been discontinued. One child continues on long term ventilation due to other comorbidities. Asfotase alpha has been shown to improve skeletal mineralization and may have a direct impact on airway malacia although this has not been fully investigated. We do know that it at least indirectly aids by supporting growth of the child and therefore the airway caliber and cartilage rigidity also improves with age.

As demonstrated, our case series shows that these children now have a good prognosis. With timely, sometimes antenatal diagnosis and a multidisciplinary approach, novel therapies and airway support via long term ventilation mean that these children have been able to survive infancy and have their respiratory support removed as they have grown. Objective: The purpose of this case report is to summarize the clinical characteristics, diagnostic workup and outcome of a patient affected by ROHHAD syndrome.

Method: We retrospectively reviewed the patient's clinical history.

Rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation (ROHHAD) syndrome is an infrequent but known clinical entity, and a possible cause of consulting to the pediatric pulmonology clinic as a sleep-related disorder. It is considered one of the nocturnal hypoventilation differentials; it might also present as a chronic progressive entity, such as the case present herein, highlighting the diagnostic challenge of this uncommon disease. Finally, elevated BAL concentrations of substance P and of pepsin were observed, not statistically different in the WAR and AR groups.

Conclusions: In this patient population, WAR events can be associated with a significant airway inflammation and injury that, because of the biochemical mechanisms involved, are likely not completely preventable and/or counteracted by anti-acid treatments.

Review. Objectives: To review the management and differential diagnosis of early-onset pulmonary disease, especially when associated with vasculitic skin rash and persistently high systemic inflammatory markers.

Case Report: A 6-month-old boy was admitted to evaluate failure to thrive after starting cow's milk feeding at 4 months of age. On examination, he had tachypnea (75 breaths/min) and chest X-ray was abnormal with a diffuse interstitial pattern.

He was a full term newborn with no other previous history of interest apart from some choking on feedings and cough and cyanosis while crying. His mother, sister and grandmother were celiac. His mother suffered from diabetes and hypothyroidism.

He was then studied for sweat test, tuberculin skin test, echocardiography, abdominal ultrasound; all were normal. Erythrocyte sedimentation rate (ESR) was 71 mm/h, IgG was elevated (2100 mg/dl), and his chest CT showed diffuse ground-glass opacities and septal thickening. At bronchoalveolar lavage (BAL), 40% of lymphocytes and 20% of neutrophils were found. A 24-hour esophageal pH-metry showed severe gastroesophageal reflux, thus omeprazole was started.

A pulmonary biopsy at 8 months of age revealed septal widening with lymphocytic T and B aggregates in the interstitium and the airways.

Serum precipitating IgG antibodies to cow's milk proteins were positive, and an initial tentative diagnosis of milk-induced hypersensitivity pulmonary disease was made. A cow's milk-free diet was initiated, with an improvement in growth.

He was administered several boluses of high-dose steroids but no significant respiratory improvement was observed.

At the age of 14 months, he started having a macular rash on the cheeks and ear nodules that worsened with cold. During the following months, this rash extended and became purpuric-necrotic. A skin biopsy showed leukocytoclastic vasculitis and interface dermatitis. When he was 5 years old, Tocilizumab was started. There was a clear improvement both clinically and blood test-wise, nonetheless this treatment had to be stopped due to muscular toxicity after 4 months.

At six years of age in 2014 (after publication of this new entity: N Engl J Med 2014;371:507-18), this patient was found to have a mutation at the TMEM173 gen and SAVI syndrome was diagnosed.

Since the age of 3, he has been asymptomatic from the respiratory standpoint having only some dyspnea on heavy exercise. Currently he is 9 years old and has been following treatment with Ruxolitinib for two years now. There seems to be a good clinical response but ESR is still It is important to include interferonopathies such as SAVI syndrome in the differential diagnosis of a child with interstitial lung disease, especially when associated with persistently increased acute-phase reactant levels and progressive skin damage. Vo2max (O2 consumption at maximal exercise) was within normal range with large variability (94 + 24% predicted). The maximal load achieved was 85 + 16% predicted and the ventilatory anaerobic threshold appeared earlier than expected (< 40% VO2max) in 53% of cases. Ventilatory breathing reserve was normal in most children (VE/ MVV-66 ± 16%). O2 pulse was within normal range, but with large variability (VO2 pulse-86 + 21% predicted). No significant heart rhythm abnormalities were observed.

VD/VT at maximal exercise was 31 ± 5% and tidal volume at maximal exercise was increased to 0.44 ± 0.09Xvital capacity, both suggesting less efficient ventilation.

PE patients tended to be tachypneic at maximal exercise (respiratory rate-118 + 29% predicted).

Pulmonary equivalents at maximal exercise were elevated, suggesting less effective gas exchange in these patients.

Severe PE was associated with lower maximal load, with no difference in VO2 max and other ventilatory measurements.

Respiratory symptoms were associated with lower VO2max and higher respiratory equivalents compared to asymptomatic patients. Unfortunately, pediatricians' adherence to the guidelines remains low 7,8,9 . This may be attributed to lack of physician awareness and familiarity with published guidelines, as well as a lack of knowledge regarding available tools. It is essential that pediatric pulmonologists, who manage primarily diseases that are directly affected by SHSe, adhere to published guidelines.

Purpose of Study: Data regarding whether pediatric pulmonologists adhere to guidelines is lacking. We conducted a survey to assess pediatric pulmonologists' practices with respect to SHSe screening, counseling, treatment, and referral to cessation services. Results: Eighty responses were obtained. Only 1% stated they always use the AAP and ACCP clinical practice guidelines. Although respondents reported always screening (93%) and counseling (77%), only 27% referred caregivers. Zero percent responded to always prescribing nicotine replacement therapy (NRT), bupropion, and varenicline. Over 55% of respondents did not feel comfortable treating tobacco dependence in caregivers but only 41% responded that they would attend a cessation training course if offered at a national meeting.

Conclusion and Discussion: Compared to our cohort of general pediatricians, the rate of screening and counseling of the respondents was higher but the rate of treatment and referral was similar 7 . Despite the morbidity of SHSe in common pulmonary diseases like bronchopulmonary dysplasia 11 , cystic fibrosis 12 , and asthma 13 , pediatric pulmonologists are not using available tools to assist smoking caregivers. It is imperative that physicians who treat children with respiratory disorders feel confident in treating caregivers' tobacco dependence. A revision of pediatric pulmonary training programs' curriculum is needed and should include tobacco cessation training to assure graduates are able to be actively involved and at the forefront of treating the tobacco epidemic. In comparing the distribution of discrete variables between two groups, the chi-square test or Fisher's exact test, when appropriate, was performed. Bartlett's test for homogeneity was used to determine if 2 groups were the same or not. All tests were performed at a significance level at P < 0.05.

A total of 48 patients out of 50 predicted sample size of critically ill patients were recruited for the study. Of the 50 patients recruited, 48 were discharged, 1 was withdrawn from the control group from the study due to mortality and another was also withdrawn from the arginine group due to mortality. Both patients died from their primary disease of Pediatric Community Acquired Pneumonia D less than 48 hours after admission. Statistical analysis also showed that there was no statistical difference in arginine levels between arginine group and the placebo group, before and after supplementation, using the Bartlett's Test, P value 0.120 and 0.074 respectively and degrees of freedom 1. The lack of statistical significance may be attributed to the dose given to our subjects, which is a maximum of 3000 grams a day. There were no readmissions and no adverse effects noted.

Arginine supplementation has no effect in the prevention of occurrence of nosocomial infection in patients that are critically ill.

However, further studies are highly recommended and use of a higher dose of arginine supplementation at 3000 grams −8000 grams is encouraged.

Even with the low dose of arginine that was used in this study, the results are promising. It is imperative that we perform further investigation using a high dose of arginine. Maybe with higher doses, the positive effect will be better demonstrated and a statistical difference will be achieved in the prevention of nosocomial infection. Conclusions: Severe asthmatic children who have been hospitalized in Concepcion registered in their medical history that they have received a quantity of radiation stemming mainly from chest X-rays for which the median is equal to 17% of annual base radiation. Some patients must be followed over time in order to look for certain secondary effects of radiation exposure.

Wang Y., Chen Z., Yang D. Poor spatial resolution QOL questionnaires were sought. Demographics of the two groups were compared by unpaired t-test. Fisher's exact test, Pearson, chi square test, and correlation were performed as needed.

Results: 19 CF (58% male, mean age 17.6 ± 11.2 years) and 17 BO patients (59% mean age 14.7 ± 5.9 years) were recruited. No statistically significant differences were found between CF and BO patients in pulmonary function tests, LCI, and SF-36 QOL questionnaire score.

The mean 6MWT score was similar in both groups, 461.8 ±67.2 m compared to 502.6 ±70 m in CF and BO patients respectively (p = 0.083).

While in CF patients, the 6-MWT score correlated negatively with percent predicted LCI (r = −0.519, p = 0.047), in our small BO group no such correlation was found.

No correlation was found between 6MWT scores and SF-36 QOL questionnaire score in both CF and BO patients. Our work focused on BM width, as a sign of airway wall remodeling. In a wide age spectrum group of patients, we investigated its relationship to anthropometrical and lung function parameters, which may be its determinants (measured non-invasively). Our data Background: The transition from early childhood wheezing to persistent asthma is linked to lung function impairment over time.

Little is known how the methods used to study lung function at different ages correlate longitudinally.

Methods: Sixty-four children with a history of hospitalization for bronchiolitis before six months of age were prospectively studied with impulse oscillometry (IOS) at the mean age of 6.3 years and these preschool IOS results were compared with flow-volume spirometry (FVS) measurements at mean age of 11.4 years.

Results: The baseline respiratory system resistance at 5 Hz (Rrs5) showed a modest statistically significant correlation with all baseline were performed by neonatologists, while routine SpO2 monitoring was continued routinely throughout these procedure. The specimens were immediately taken for accurate measurement to our hospital laboratory. Analysis: The difference between sampled Hb and SpHb was evaluated on linear regression and Bland-Altman analysis.

Results: Thirty-three infants aged 5 days to 112 days (median 15 days) with body weights ranging from 956 to 3.160 grams (median 2.195 grams) were studied and 44 samples were analyzed. Eleven infants underwent a second sampling after an interval of more than 2 weeks due to medical necessity. In all cases, there were no adverse events due to measurement of SpHb and blood sampling in this study. The difference between sampled Hb and SpHb levels fell mostly within the ± 2g/dL range with a fair correlation (R = 0.73). The

Bland and Altman Plot indicated that this prototype system tended to show relatively high SpHb values when sampled Hb levels were below almost 13.0 g/dL, and 95% limits of agreement were from-4.046 to 3.077.

Discussion: The correlation between SpHb and sampled Hb levels is good. SpHb device appeared feasible, even if the device was used for neonates or infants below 3 kg at a wide range of Hb levels. By attaching this SpHb device in neonates or infants below 3 kg, it is possible to detect an anemia faster and to reduce unnecessary blood tests. Furthermore, pulmonary edema and circulation failure caused by excess blood transfusion may be prevented. Erythropoietin therapy is given to anemia of prematurity below Hb 12g/dL. In infants weighing less than 3 kg, SpHb tended to exhibit higher values than sampled Hb when the latter levels were below almost 13.0 g/dL. Therefore SpHb could underestimate an anemia. When SpHb was measured on a lower extremity and the sampled blood Hb was taken from an upper extremity, there was almost no difference in these values. From this fact, it is considered that the measurement location can be anywhere.

It is more likely that the bioengineering factors in measurement play a significant role in this data skewing, although we do not currently have access to the information needed.

Conclusion: Application of a prototype SpHb device appeared feasible for neonates or infants below 3 kg at a wide range of Hb levels. It may be possible to measure pulmonary and hemodynamic conditions without collection of blood at the same time with a noninvasive method. However, at this time, with the SpHb device, there is still room for improving the accuracy when levels were below almost 13.0 g/dL.

Data obtained in this study should be used as a reference for future improvement.

Tomography Scans Performed at a Tertiary Care Hospital. The purpose of this study was to evaluate the radiation doses to which children from 0 to <18 years of age undergoing chest computed tomography (CT) examinations in the radiology department of a tertiary care hospital are being exposed.

We performed a retrospective study of all consecutive pediatric included. Results of the meta-analysis are reported in Figures 1, 2 In our institution, on the 14 cases in which Continuous Negative

Mode of BCV was started from the emergency department, their symptoms were improved shortly in all cases. Respiratory rate and heart rate were improved in 30 minutes after starting Continuous Negative

Mode of BCV, and hypercapnia was improved in less than 1 hours. In all cases, BCV worked smoothly and the respiratory condition was improved.

For children with respiratory distress who breathe spontaneously and do not need artificial respiration, it is difficult to maintain airway pressure using bag-mask ventilation. In such cases, bag-mask ventilation is unstable as treatment. On the other hand, BCV does not require sedation and has greater mobility due to its battery power.

We can continue the same treatment after hospitalization.

We suggest that starting the treatment with BCV in the emergency department and continuing the treatment without interruption during the transportation of the patients to the ward are feasible and safe. Conclusion: VRA is a rare condition although deserves to be known by the pediatrician, the gynecologist (no prenatal diagnosis in our series) and the radiologist to be diagnosed in time. The explorations must take into account the level of irradiation, barium swallow must be abandoned and MRI must take its place in radiological exploration. Methods: Healthy children were recruited from randomly selected kindergartens in or around Florence, Italy. The subject's history of respiratory symptoms was assessed using a standardized questionnaire (ISAAC modified), translated into Italian [2] . Children born at less than 36 weeks of gestational age or who had received oxygen at birth for more than 30 days were excluded. Children with no more than 3 episodes of wheezing ever, but no episodes of wheezing during the previous 12 months, were included. All children had no respiratory symptoms or signs at the time of testing. Spirometry was performed with the "Spiro Cosmed" spirometer (Cosmed, Rome, Italy) according to ATS/ERS spirometry recommendations for preschoolers [3] . Potential Study Limitation: The number of subjects enrolled in the study, to confirm the validity of these reference equations (GLI-2012), was less than the 300 local "healthy" controls (150 males and 150 females) that would be needed to validate published reference equations with any degree of certainty, since with smaller sample size differences of up to 0.5 z-scores may occur purely by chance [4] .

Furthermore, this relative inclusion flexibility has been used to select a sample closer to the reality of the population, to avoid selecting "abnormally normal" children, which would distort the study, resulting in an overestimation of the results; this is still a topic of many discussions regarding what would be the "normal" parameters necessary to be considered [5] 1 Khoo Teck Puat-National University Children's Medical Institute, National University Hospital − Singapore; 2 Wee Kim Wee School of Communication and Information, Nanyang Technological University − Singapore, Singapore Background/Objectives: Sleep is essential for optimal body functioning. The National Sleep Foundation recommends that primary school children get 9-11 hours of sleep per day. A previous study in Singapore showed that sleep duration is significantly lower in preschool children when compared to Western populations. There is little published data on the sleep habits of primary school children in Singapore. Our study aims to investigate sleep practices amongst lower primary school age children in Singapore.

Methods: This was a questionnaire survey of parents with children aged between 6 and 9 years old attending primary schools in Singapore. Aim: The study aims to determine the prevalence of SDB, its behavioral manifestations and associated risk factors for poor score in children in a South-Eastern Nigerian city.

Methods: A community-based descriptive study was conducted using the child sleep questionnaire (SRBD subscale-070129). Children aged 1 month to 18 years from consenting households were recruited.

Results: Three hundred and ninety nine proxy-reports were analyzed.

The mean age was 70 ± 43 months, with a male to female ratio of 1:1. Results: The average rate of bacterial contamination of NICU of was 73%. The most contaminated areas were washing sink (98%), suction (74%) and the lowest was phototherapy (35%) and oxygen mask (44%), respectively. The most frequent bacteria isolated were as follows:

Staphylococcus epidermidis (17%), Bacillus subtilis (12.5%), Acinetobacter baumannii (11.3%) and E. coli (8.2%). Most of the isolates (60%-90%) were sensitive against imipenem, ceftriaxone, vancomycin, cefepime and ciprofloxacin, whereas most of them were resistant to ampicillin, gentamicin, erythromycin and cephalexine.

Our results showed the considerable bacterial contamination (73%) of NICU in particular with Acinetobacter baumannii and the high drug resistance in strains isolated from hospital; it seems that sterilization and disinfection methods in hospitals were not performed In children with a diagnosis of OSA, poor compliance with prescribed therapy was described (43% never use night-time CPAP). Compliance and perception of benefit were directly related to each other. This has an immediate and long term impact. However, those that wear CPAP report a clear benefit as most describe treatment as moderately or extremely successful.

One quarter of parents reported recurrent chest infections. One third reported concerns regarding swallow. Method: Observational, retrospective study of the children who were attended at the healthy child's review in our clinic for 9 months. The number of hours of sleep was recorded, including the difference between day and night hours. Each patient was associated with a percentile according to graphs currently used as a reference (Iglowstein, 2003) . The data were analyzed bearing in mind the different age ranges for the elaboration of a representative percentile chart of our population. 4-A 12-year-old boy who sleeps 9 hours a day: 50th percentile vs. 25th

percentile.

5-A 12-year-old boy who sleeps 7 hours a day: percentile 3 vs.

percentile <1.

Conclusions: The graphs currently used as a reference for sleep are not representative of our population because there are cultural and geographical differences.

Sleep percentiles obtained from the analysis of our population clearly differ from those currently used as a reference. The percentile ranges obtained after the analysis of our population are clearly lower than those currently used as a reference. The use of the graphs originated after the study of our population would allow us to identify more effectively those patients with sleep deprivation and therefore at risk of developing secondary problems to this sleep deprivation.

N197 − A rare case of hemoptysis: mucoepidermoid carcinoma of the lung in a 12-year-old boy.

Introduction: We present a case of a 12-year-old boy with a 12-month history of chronic cough and hemoptysis.

Case report: A 12-year-old boy with poorly controlled asthma, who was treated with inhaled steroids during exacerbations, presents

with a year-long history of predominant nocturnal, productive cough, associated with two episodes of hemoptysis. There were no other relevant respiratory symptoms. A chest X-ray was performed and revealed a right upper lobe collapse and consolidation, leading to his referral to our institution for a thorough diagnostic workup.

There was no history of foreign body aspiration, fever, night sweats or weight loss. He underwent an initial flexible bronchoscopy that showed an endobronchial exophytic nodular lesion at the right upper lobe (see figure 1 ). Given his longstanding history of respiratory symptoms and the area from which he was referred, our initial diagnosis presumption was endobronchial tuberculosis.

Nevertheless, his tuberculin skin test was 0 mm and both Ziehl Currently, the patient continues under routine surveillance, he is thriving well, asymptomatic and his lung function remains stable.

Conclusion: Among the rare causes of hemoptysis which the pediatric pulmonologist can expect to encounter, tumors such as pulmonary adenomas or carcinomas may be present, particularly in older children.

Therefore, malignancy must be always considered as part of the differential diagnosis of persistent hemoptysis in children with no underlying chronic lung disease.

Mucoepidermoid carcinoma is a rare disease that accounts for less than 1% of primary malignant lung tumors. They are derived from 

Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke. A Report of the Surgeon General

Best D; Committee on Environmental Health; Committee on Native American Child Health

Implementation of a Parental Tobacco Control Intervention in Pediatric Practice

Committee on Adolescence; Committee on Native American Child Health. From the Academy of Pediatrics: Policy Statement-Tobacco use: a pediatric disease

Flexible bronchoscopy in children: Utility and complications

Objective: This part of the International Study of Asthma and Allergies in Childhood (ISAAC) Phase III was to determine the prevalence of asthma, allergic rhinitis and atopic eczema among schoolchildren age 6-7 years and 13-14 years

Pediatric Department B, Children Hospital of Tunis − Tunis

Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations

International study of asthma and allergies in childhood (ISAAC): rationale and methods

An Official American Thoracic Society/European Respiratory Society Statement: Pulmonary Function Testing in Preschool Children

Influence of secular trends and sample size on reference equations for lung function tests

How "healthy" should children be when selecting reference samples for spirometry?

Thus, we recommended that health workers should be

Purpose: The aim of our study was to describe the contribution of HFNC in the management and evolution of severe bronchiolitis.

We retrospectively studied cases of severe bronchiolitis for three months (November 1, 2015 − January 31, 2016). We compared two groups: a first group including the cases of severe bronchiolitis in which HFNC was used, and a second group including patients who were not placed under HFNC due to lack of availability.Conclusions: This is the first study with the aim to assess the validity of the GLI-2012 reference values in preschool Italian children. These data so far suggest that the difference between measured and predicted values using GLI-2012 is neither statistically nor clinically significant in healthy Italian preschoolers.Abstract: Although the diagnosis of bronchiolitis is usually straightforward, cardiac, metabolic, musculoskeletal and hematological conditions may present in a similar way and therefore, should not be overlooked.

We describe four cases presenting with increased work of breathing that were treated initially as bronchiolitis. However, the progressive clinical course of these cases and further investigations revealed an alternative diagnosis.Results: The first case was a 36-week baby boy who presented with symptoms of bronchiolitis and was treated accordingly. A slow response to treatment and a subsequent CT scan revealed the diagnosis of congenital lobar emphysema, which needed resection.